These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The rheumatologic complications of hematologic disorders. Isenberg DA, Shoenfeld Y. Semin Arthritis Rheum; 1983 May; 12(4):348-58. PubMed ID: 6348950 [No Abstract] [Full Text] [Related]
4. [Treatment with growth factors and cytokines in hematologic diseases]. Waage A, Dahl IM, Evensen SA, Holte H, Lamvik J, Sletnes K, Wisløff F. Tidsskr Nor Laegeforen; 1996 May 10; 116(12):1465-9. PubMed ID: 8650635 [Abstract] [Full Text] [Related]
5. Musculoskeletal complications of haematological disease. Morais SA, du Preez HE, Akhtar MR, Cross S, Isenberg DA. Rheumatology (Oxford); 2016 Jun 10; 55(6):968-81. PubMed ID: 26443208 [Abstract] [Full Text] [Related]
6. The use of G-CSF and GM-CSF in bone marrow transplantation. Bolwell BJ. Cleve Clin J Med; 1993 Jun 10; 60(4):291-302. PubMed ID: 7687938 [Abstract] [Full Text] [Related]
10. Rheumatologic features of hematologic disorders. Mody GM, Cassim B. Curr Opin Rheumatol; 1996 Jan 10; 8(1):57-61. PubMed ID: 8867541 [Abstract] [Full Text] [Related]
11. [Cytokines in the treatment of blood diseases]. Robak T. Acta Haematol Pol; 1995 Jan 10; 26(2 Suppl 1):72-8. PubMed ID: 7544526 [Abstract] [Full Text] [Related]
12. The levels of granulocyte colony-stimulating factor in the plasma of the bone marrow aspirate in various hematological disorders. Shinohara K, Oeda E, Nomiyama J, Inoue H, Kamei S, Tajiri M, Ichikawa T, Kuwaki T, Tachibana K. Stem Cells; 1995 Jul 10; 13(4):421-7. PubMed ID: 7549901 [Abstract] [Full Text] [Related]
13. [Rheumatic-type manifestations in patients with malignant hemopathies]. Parasca I, Duţu A, Osman A. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985 Jul 10; 37(4):369-75. PubMed ID: 2865799 [No Abstract] [Full Text] [Related]
14. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose? Elfenbein GJ. Pediatr Transplant; 2005 Dec 10; 9 Suppl 7():37-47. PubMed ID: 16305616 [Abstract] [Full Text] [Related]
15. Granulocyte colony-stimulating factor administration: adverse events. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P. Transfus Med Rev; 2008 Oct 10; 22(4):280-90. PubMed ID: 18848155 [Abstract] [Full Text] [Related]
17. Rheumatologic manifestations of gastrointestinal disorders. Mody GM, Cassim B. Curr Opin Rheumatol; 1998 Jan 10; 10(1):67-72. PubMed ID: 9448992 [Abstract] [Full Text] [Related]
18. [The use of G-CSF in hematological disorders]. Dan K. Rinsho Ketsueki; 1997 May 10; 38(5):367-70. PubMed ID: 9194376 [No Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation in chronic myeloid leukaemia. Divya. Natl Med J India; 1998 May 10; 11(1):19-21. PubMed ID: 9557515 [No Abstract] [Full Text] [Related]
20. Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel. Schaison G, Eden OB, Henze G, Kamps WA, Locatelli F, Ninane J, Ortega J, Riikonen P, Wagner HP. Eur J Pediatr; 1998 Dec 10; 157(12):955-66. PubMed ID: 9877032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]